论文部分内容阅读
肾上腺素能阻滞剂的应用是青光眼治疗的一个里程碑。倍他索洛尔(betaxolol)用于口服或静脉注射是安全和有效的。在一年的观察中,发现局部以0.25％倍他索洛尔滴眼对慢性开角型青光眼或高眼压患者有效。在治疗开始前作全面的眼科检查。本研究采取双盲法随机将10名患者分为倍他索洛尔组和对照组。患者滴眼每次1滴,每天上午9时和下午9时各滴1次。每组在第1、2、4和6周末的同一时间进行观察。研究结
Adrenergic blockers are a milestone in the treatment of glaucoma. Betaxolol is safe and effective for oral or intravenous injection. During a year of observation, topical 0.25% betaxololol was found to be effective in patients with chronic open-angle glaucoma or ocular hypertension. Before the start of treatment for a comprehensive eye examination. In this study, a double-blind randomized 10 patients were divided into Betalovolol group and control group. Patients drop 1 drop each time, every day at 9:00 am and 9:00 each drop 1. Each group was observed at the same time on the 1st, 2nd, 4th, and 6th weekend. Study Results